Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    Mexazolam molecular structure

    Mexazolam Stats & Data

    Melex Sedoxil
    NPS DataHub
    MW363.24
    FormulaC18H16Cl2N2O2
    CAS31868-18-5
    IUPAC10-chloro-11b-(2-chlorophenyl)-3-methyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one
    SMILESClc1ccc2NC(=O)CN3C(C)COC3(c3ccccc3Cl)c2c1
    InChIKeyANUCDXCTICZJRH-UHFFFAOYSA-N
    Chemical Class Oxazolobenzodiazepine
    Psychoactive Class Depressant

    Pharmacology

    DrugBank

    Description

    Mexazolam (CS-386) is a benzodiazepine indicated for the treatment of anxiety with or without psychoneurotic conditions. Mexazolam's structure is similar to that of other benzodiazepines such as oxazolam and cloxazolam. The use of benzodiazepines in the treatment of anxiety is generally a second line measure.

    Mechanism of Action

    Mexazolam is a benzodiazepine that binds to benzodiazepine-type receptors, inhibiting gamma-aminobutyric acid.

    Metabolism

    Mexazolam is rapidly metabolized to the active metabolites chloronordiazepam and chloroxazepam.

    Absorption

    The active metabolite chloronordiazepam has a Tmax of 1-2h.

    Indication

    Mexazolam is indicated for the treatment of anxiety with or without psychoneurotic conditions.

    Half-life

    Mexazolam follows a 2 compartment model with a first half life of 1.4h and a second half life of 76h.

    Protein Binding

    Mexazolam is >90% protein bound in plasma.

    Elimination

    Mexazolam is mainly eliminated in the bile and feces, with <10% eliminated as metabolites in the urine. >50% of a dose of mexazolam is eliminated as the metabolite chloroxazepam.

    Toxicity

    PubChem

    Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor.

    Carcinogenicity

    No indication of carcinogenicity to humans (not listed by IARC).

    Tolerance & Pharmacokinetics

    drugs.wiki

    No tolerance chart. Our decay curves for these drugs were estimates, and a curve can make tolerance look longer-lasting than it is, which is the dangerous direction.

    How fast tolerance to these drugs fades after a break has not been measured well enough to draw, so don't count on a dose you used to take still being safe: after time off, start with a much smaller amount and don't use alone. Mixing sedatives with each other, with alcohol or with opioids sharply raises the risk of a fatal overdose. If you've been using regularly, don't stop suddenly: withdrawal from benzodiazepines, alcohol or GHB/GBL can cause seizures or delirium, so get medical help to cut down gradually.

    Sources: FRANK: benzodiazepines · Alcohol and Drug Foundation: GHB · FDA 2020: benzodiazepine boxed warning · FDA 2019: gabapentinoids and breathing · NHS: alcohol use disorder

    ← Back to Mexazolam